Submitted by Alex Hicks on Wednesday 22nd November 2023
Published on Monday 18th December 2023
Current status: Open
Open until: Tuesday 18th June 2024
Current Signatures: 8,320
(count is updated approximately hourly)
Review how to turn MHRA into a fully transparent, patient first regulator
We believe the MHRA should be reviewed. This should include its approval processes, its monitoring of safety of existing products, its transparency and accountability, and its mechanisms to ensure patient safety is prioritised over commercial interests.
The review should also cover how conflict of interests can be eradicated, improving the yellow card process, and limiting its funding sources. A wide range of medicines & devices approved by MHRA have caused patient harm. We believe the MHRA focuses too much on clinical trials of new medicines, rather than safety of existing ones.
Information sought through FOIs has sometimes not been provided due to commercial interests.
There is a 'revolving door' between industry & the regulator, board members have declared financial interests in the pharmaceutical industry.
If you want to sign this petition (as opposed to merely discuss it), you need to do that on the government's e-Petitions website.
184.108.40.206 Sun, 03 Mar 2024 08:10:36 +0000